Journey Medical Corp Amortization of Debt Issuance Costs
Journey Medical Corp (DERM) reported Amortization of Debt Issuance Costs of $99.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-12
- Journey Medical Corp amortization of debt issuance costs for the quarter ending 2026-06-30 was $99.00K, a 20.16% decline year-over-year.
- Journey Medical Corp amortization of debt issuance costs for the quarter ending 2026-03-31 was $96.00K, a 5.88% decline year-over-year.
- Journey Medical Corp amortization of debt issuance costs for the quarter ending 2025-09-30 was $123.00K, a 41.38% increase year-over-year.
- Journey Medical Corp amortization of debt issuance costs for the quarter ending 2025-06-30 was $124.00K, a 93.75% increase year-over-year.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month |
|---|---|---|---|
| 2026-06-30 | $99.00K 10-Q · filed 2026-08-12 | $195.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $96.00K 10-Q · filed 2026-05-13 | ||
| 2025-09-30 | $123.00K 10-Q · filed 2025-11-12 | $247.00K derived: sum of 2 quarters · filed 2026-08-12 | $348.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $124.00K 10-Q · filed 2026-08-12 | $225.00K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $102.00K 10-Q · filed 2026-05-13 | ||
| 2024-09-30 | $87.00K 10-Q · filed 2025-11-12 | $151.00K derived: sum of 2 quarters · filed 2025-11-12 | $213.00K 10-Q · filed 2025-11-12 |
| 2024-06-30 | $64.00K 10-Q · filed 2025-08-12 | $126.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $62.00K 10-Q · filed 2025-05-15 | ||
| 2023-09-30 | $58.00K 10-Q · filed 2024-11-12 | $330.00K derived: sum of 2 quarters · filed 2024-11-12 | $354.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $272.00K 10-Q · filed 2024-08-13 | $297.00K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-14 | ||
| 2022-09-30 | $90.00K 10-Q · filed 2023-11-13 | $177.00K derived: sum of 2 quarters · filed 2023-11-13 | $257.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $87.00K 10-Q · filed 2023-08-10 | $167.00K 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $80.00K 10-Q · filed 2023-05-22 |